Universidad de Alcalá (UAH)

University / College


Location: Alcala de Henares, Madrid, Spain (ES) ES

ISNI: 0000000419370239

ROR: https://ror.org/04pmn0e78

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution Resection of pancreatic cancer in Europe and USA: An international large-scale study highlighting large variations (2019) Huang L, Jansen L, Balavarca Y, Molina-Montes E, Babaei M, Van Der Geest L, Lemmens V, et al. Journal article New complexes of Ni(II) and Co(III) with a Schiff-base ligand derived from o-vanillin. Crystal structure, magnetic and catalytic properties of a dissymmetric binuclear nickel(II) complex (2018) Neacsu VA, Maxim C, Madalan AM, Hillebrand M, Gonzalez-Arellano C, Soriano S, Rentschler E, Andruh M Journal article Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study (2018) Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, et al. Journal article Chances and Risks of the Internationalization of SMEs: An Empirical Approach to German SMEs Internationalizing to Spain (2018) Schmidt MC, González Pérez CM Conference contribution, Conference Contribution Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article